Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuat...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60e60c55367c4b41bb2cc74cf1484691 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:60e60c55367c4b41bb2cc74cf1484691 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:60e60c55367c4b41bb2cc74cf14846912021-11-11T17:10:49ZLipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation10.3390/ijms2221117201422-00671661-6596https://doaj.org/article/60e60c55367c4b41bb2cc74cf14846912021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11720https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuation, such as puberty, pregnancy, or menopause. Although the identification and characterization of lipedema have improved, the underlying disease etiology remains to be elucidated. Estrogen, a key regulator of adipocyte lipid and glucose metabolism, and female-associated body fat distribution are postulated to play a contributory role in the pathophysiology of lipedema. Dysregulation of adipose tissue accumulation via estrogen signaling likely occurs by two mechanisms: (1). altered adipocyte estrogen receptor distribution (ERα/ERß ratio) and subsequent metabolic signaling and/or (2). increased release of adipocyte-produced steroidogenic enzymes leading to increased paracrine estrogen release. These alterations could result in increased activation of peroxisome proliferator-activated receptor γ (PPARγ), free fatty acid entry into adipocytes, glucose uptake, and angiogenesis while decreasing lipolysis, mitochondriogenesis, and mitochondrial function. Together, these metabolic alterations would lead to increased adipogenesis and adipocyte lipid deposition, resulting in increased adipose depot mass. This review summarizes research characterizing estrogen-mediated adipose tissue metabolism and its possible relation to excessive adipose tissue accumulation associated with lipedema.Kaleigh KatzerJessica L. HillKara B. McIverMichelle T. FosterMDPI AGarticlelipedemaadipose tissueestrogen receptorlipoprotein lipaseGLUT4peroxisome proliferator-activated receptor gammaBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11720, p 11720 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
lipedema adipose tissue estrogen receptor lipoprotein lipase GLUT4 peroxisome proliferator-activated receptor gamma Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
lipedema adipose tissue estrogen receptor lipoprotein lipase GLUT4 peroxisome proliferator-activated receptor gamma Biology (General) QH301-705.5 Chemistry QD1-999 Kaleigh Katzer Jessica L. Hill Kara B. McIver Michelle T. Foster Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
description |
Lipedema is a painful fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. The onset of lipedema pathophysiology is thought to occur during periods of hormonal fluctuation, such as puberty, pregnancy, or menopause. Although the identification and characterization of lipedema have improved, the underlying disease etiology remains to be elucidated. Estrogen, a key regulator of adipocyte lipid and glucose metabolism, and female-associated body fat distribution are postulated to play a contributory role in the pathophysiology of lipedema. Dysregulation of adipose tissue accumulation via estrogen signaling likely occurs by two mechanisms: (1). altered adipocyte estrogen receptor distribution (ERα/ERß ratio) and subsequent metabolic signaling and/or (2). increased release of adipocyte-produced steroidogenic enzymes leading to increased paracrine estrogen release. These alterations could result in increased activation of peroxisome proliferator-activated receptor γ (PPARγ), free fatty acid entry into adipocytes, glucose uptake, and angiogenesis while decreasing lipolysis, mitochondriogenesis, and mitochondrial function. Together, these metabolic alterations would lead to increased adipogenesis and adipocyte lipid deposition, resulting in increased adipose depot mass. This review summarizes research characterizing estrogen-mediated adipose tissue metabolism and its possible relation to excessive adipose tissue accumulation associated with lipedema. |
format |
article |
author |
Kaleigh Katzer Jessica L. Hill Kara B. McIver Michelle T. Foster |
author_facet |
Kaleigh Katzer Jessica L. Hill Kara B. McIver Michelle T. Foster |
author_sort |
Kaleigh Katzer |
title |
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
title_short |
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
title_full |
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
title_fullStr |
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
title_full_unstemmed |
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation |
title_sort |
lipedema and the potential role of estrogen in excessive adipose tissue accumulation |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/60e60c55367c4b41bb2cc74cf1484691 |
work_keys_str_mv |
AT kaleighkatzer lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation AT jessicalhill lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation AT karabmciver lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation AT michelletfoster lipedemaandthepotentialroleofestrogeninexcessiveadiposetissueaccumulation |
_version_ |
1718432179674939392 |